Delivery Order SPE2DB22D2206-SPE2DB25FJD07
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,545.00 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 MCG 12GM inhalers. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 4, 2025. The pharmaceutical products will be delivered to the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary distribution operations. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $2,245.93 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 MCG inhalers (12-gram units) on July 21, 2025, with completion scheduled for July 22, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Fluticasone Propionate HFA 110 micrograms in 12-gram inhalers, with a contract value of $24,494.88 and an ultimate completion date of July 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued as a competitive award under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive...
- The Defense Logistics Agency awarded a $4,577.52 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for Fluticasone Propionate HFA 220 MCG inhalers (12 grams). This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with completion targeted for July 25,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,715.83 on July 29, 2025, for the supply of Fluticasone Propionate HFA 44 microgram inhalers (10.6 grams). This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026. The product will be...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $3,948.50 to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Fluticasone Propionate HFA 220 MCG inhalers (12 GM units). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the vendor's existing Indefinite Delivery Contract with DLA Troop Support Medical. The order is scheduled for completion by July 29, 2025, with performance based at the...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 micrograms in 12-gram inhalers, valued at $1,184.52, with an ultimate completion date of August 4, 2025. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a prime pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,498.25 to AmerisourceBergen Drug Corp for the supply of Fluticasone Propionate HFA 110 micrograms in a 12-gram inhaler. This firm fixed price contract, issued on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order...
- The Defense Logistics Agency awarded a $4,535.86 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Fluticasone Propionate HFA 220 MCG inhalers (12 grams). The contract is structured as a firm fixed-price delivery order with an ultimate completion date of July 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting the...
- The Defense Logistics Agency (DLA) awarded a $7,079.35 delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 44 micrograms in 10.6-gram inhalers, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider,...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJD07Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,138.61 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 220 MCG inhalers (12GM) on July 29, 2025, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The order represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreements with DLA. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this delivery order through its existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to supply medications, vaccines, medical devices, and specialized healthcare commodities to military and federal healthcare systems. The current delivery order for the respiratory medication supports DLA's mission to provide critical medical supplies to Defense Health Agency, U.S. Coast Guard, and other government healthcare organizations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.1k | 7/29/25 |